Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes
出版年份 2016 全文链接
标题
Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes
作者
关键词
Kidneys, Type 2 diabetes, Diabetes mellitus, Oxidative stress, Urine, Fibrosis, Collagens, Renin-angiotensin system
出版物
PLoS One
Volume 11, Issue 11, Pages e0165703
出版商
Public Library of Science (PLoS)
发表日期
2016-11-02
DOI
10.1371/journal.pone.0165703
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- An Atherogenic Paigen-Diet Aggravates Nephropathy in Type 2 Diabetic OLETF Rats
- (2015) Masanori Nozako et al. PLoS One
- Changes in Diabetes-Related Complications in the United States, 1990–2010
- (2014) Edward W. Gregg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice
- (2014) Naoto Terami et al. PLoS One
- Diabetic Kidney Disease: From Epidemiology to Clinical Perspectives
- (2014) Cheol Whee Park Diabetes & Metabolism Journal
- A Novel Therapeutic Agent for Type 2 Diabetes Mellitus: SGLT2 Inhibitor
- (2014) Chang Hee Jung et al. Diabetes & Metabolism Journal
- Tofogliflozin, a novel sodium-glucose co-transporter 2 inhibitor, improves renal and pancreatic function indb/dbmice
- (2013) T Nagata et al. BRITISH JOURNAL OF PHARMACOLOGY
- Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes
- (2013) R. A. DeFronzo et al. DIABETES CARE
- Sodium-glucose cotransporter inhibition: therapeutic potential for the treatment of type 2 diabetes mellitus
- (2013) Philip Raskin DIABETES-METABOLISM RESEARCH AND REVIEWS
- Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice
- (2013) Atsuo Tahara et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Aberrant Activation of the Intrarenal Renin-Angiotensin System in the Developing Kidneys of Type 2 Diabetic Rats
- (2013) Y.-Y. Fan et al. HORMONE AND METABOLIC RESEARCH
- SGLT2 inhibitors enter crowded diabetes space
- (2013) Aaron Bouchie NATURE BIOTECHNOLOGY
- Effects of Combining Linagliptin Treatment with BI-38335, A Novel SGLT2 Inhibitor, on Pancreatic Islet Function and Inflammation in db/db Mice
- (2012) L. Chen et al. CURRENT MOLECULAR MEDICINE
- Sodium glucose cotransporter 2 and the diabetic kidney
- (2012) Muralikrishna Gangadharan Komala et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Dapagliflozin
- (2012) Greg L. Plosker DRUGS
- Dapagliflozin: a review on efficacy, clinical effectiveness and safety
- (2012) Angela J Paisley et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Dapagliflozin: A Novel Sodium-Glucose Cotransporter Type 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
- (2012) Niren K. Shah et al. PHARMACOTHERAPY
- The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic rats
- (2010) F. R. Macdonald et al. DIABETES OBESITY & METABOLISM
- Pathologic Classification of Diabetic Nephropathy
- (2010) T. W. C. Tervaert et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- SGLT2 inhibition — a novel strategy for diabetes treatment
- (2010) Edward C. Chao et al. NATURE REVIEWS DRUG DISCOVERY
- High Glucose Upregulates Upstream Stimulatory Factor 2 in Human Renal Proximal Tubular Cells through Angiotensin II-Dependent Activation of CREB
- (2010) Nishant P. Visavadiya et al. NEPHRON EXPERIMENTAL NEPHROLOGY
- Peroxisome proliferator-activated receptor-α activator fenofibrate prevents high-fat diet-induced renal lipotoxicity in spontaneously hypertensive rats
- (2009) Seok Joon Shin et al. HYPERTENSION RESEARCH
- Mechanism of VEGF expression by high glucose in proximal tubule epithelial cells
- (2009) Denis Feliers et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Remogliflozin Etabonate, in a Novel Category of Selective Low-Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors, Exhibits Antidiabetic Efficacy in Rodent Models
- (2008) Y. Fujimori et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- AT2 receptors: Functional relevance in cardiovascular disease
- (2008) Emma S. Jones et al. PHARMACOLOGY & THERAPEUTICS
- The importance of the intrarenal renin–angiotensin system
- (2008) Juan Carlos Q Velez Nature clinical practice. Nephrology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started